Technology | April 01, 2009

Mortara Introduces Wireless ECG Technology Platform

April 1, 2009 - Mortara Instrument unveiled its new go wireless technology platform with the introduction of its Wireless Acquisition Module (WAM) for resting ECG and the T12 transmitter for wireless stress exercise testing.

The go wireless platform is comprised of proprietary Mortara technology that is specifically designed to offer an equivalent or lower cost alternative to wired designs in ECG applications. The go wireless technology is optimized for diagnostic ECG acquisition with simple configuration, long battery life, and robust transmission protocols to be integrated into a wide array of ECG acquisition products.

The wireless acquisition module (WAM) is the first go wireless product for resting ECG acquisition to be introduced. The WAM is a high-fidelity diagnostic ECG acquisition module with integrated go wireless capabilities enabling transmission to Mortara ELITM electrocardiographs. At the touch of a button an ECG can be acquired or rhythm strip initiated. The wireless capability eliminates the traditional expensive and bulky ECG cable and allows caregivers greater freedom of movement while acquiring electrocardiograms.

Built upon the go wireless technology, the WAM is targeted to simply replace traditional patient cable designs. The company said the wireless technology offers a cost-effective improvement over traditional patient cables and offers patients freedom of movement to help ease ECG acquisition and improve workflow.

In addition to the WAM, Mortara Instrument also introduced its T12 transmitter for wireless stress exercise testing. The T12 transmitter, in conjunction with the X-Scribe Stress Exercise System, enables stress test procedures to be performed without the traditional bulky patient cable tethering the patient to the exercise system. Built upon the same go wireless technology platform, it is likewise designed to meet the price of traditional, wired solutions.

For more information: www.mortara.com


Related Content

News | ECG

March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...

Home March 06, 2026
Home
News | ECG

March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home March 04, 2026
Home
News | ECG

Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...

Home February 24, 2026
Home
News | ECG

Feb. 18, 2026 — Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and ...

Home February 20, 2026
Home
News | ECG

Dec. 10, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to HeartBeam, Inc. for its 12 ...

Home February 16, 2026
Home
News | ECG

Jan. 8, 2026 — AccurKardia recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the ...

Home January 15, 2026
Home
News | ECG

Jan. 13, 2026 — AliveCor has received U.S. Food and Drug Administration (FDA) clearance for the next generation of KAI ...

Home January 14, 2026
Home
News | ECG

Oct. 8, 2025 — Viz.ai recently launched Viz ACS, a new solution in the Viz Cardio Suite. Designed to unite the acute ...

Home October 09, 2025
Home
News | ECG

Aug. 14, 2025 — During HeartBeam, Inc.'s second quarter 2025 earnings conference call, the medical technology company ...

Home August 15, 2025
Home
News | ECG

July 24, 2025 — Royal Philips has announced a collaboration with Epic to integrate Philips’ suite of cardiac ambulatory ...

Home July 24, 2025
Home
Subscribe Now